Panel Discussion: Driving Safer Delivery of RNA Therapeutics & Vaccines by Leveraging Computational Tools with Better Prediction of Targeting & Specificity
Time: 12:00 pm
day: Day Two
Details:
- What makes antibody/ligand engineering different between general applications vs RNA-specific ones?
- How does engineering address processes after binding a target cell?
- Uncovering which factors to consider when deciding the tool to be used for a specific problem
